BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20479288)

  • 1. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.
    Hernández JM; García JL; Gutiérrez NC; Mollejo M; Martínez-Climent JA; Flores T; González MB; Piris MA; San Miguel JF
    Am J Pathol; 2001 May; 158(5):1843-50. PubMed ID: 11337382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
    Philip AZ
    J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
    Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
    Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).
    Baró C; Salido M; Espinet B; Astier L; Domingo A; Granada I; Millà F; Carrió A; Costa D; Luño E; Hernández JM; Campo E; Florensa L; Ferrer A; Salar A; Bellosillo B; Besses C; Serrano S; Solé F
    Leuk Res; 2008 May; 32(5):727-36. PubMed ID: 18023866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
    Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
    Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
    Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
    Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.
    Bardi A; Cavazzini F; Rigolin GM; Tammiso E; Volta E; Pezzolo E; Formigaro L; Sofritti O; Daghia G; Ambrosio C; Rizzotto L; Abass AE; D'Auria F; Musto P; Cuneo A
    J Biomed Biotechnol; 2011; 2011():691493. PubMed ID: 21629757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
    Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
    Granai M; Amato T; Di Napoli A; Santi R; Vergoni F; Di Stefano G; Mancini V; Kovalchuk S; Cencini E; Carta AG; Aversa S; Ziepert M; Cevenini G; Lazzi S; Leoncini L; Bellan C
    Virchows Arch; 2020 Jul; 477(1):143-150. PubMed ID: 31802229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
    Callet-Bauchu E; Baseggio L; Felman P; Traverse-Glehen A; Berger F; Morel D; Gazzo S; Poncet C; Thieblemont C; Coiffier B; Magaud JP; Salles G
    Leukemia; 2005 Oct; 19(10):1818-23. PubMed ID: 16094418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.
    Solé F; Salido M; Espinet B; Garcia JL; Martinez Climent JA; Granada I; Hernández JM; Benet I; Piris MA; Mollejo M; Martinez P; Vallespí T; Domingo A; Serrano S; Woessner S; Florensa L
    Haematologica; 2001 Jan; 86(1):71-7. PubMed ID: 11146574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
    Rinaldi A; Mian M; Chigrinova E; Arcaini L; Bhagat G; Novak U; Rancoita PM; De Campos CP; Forconi F; Gascoyne RD; Facchetti F; Ponzoni M; Govi S; Ferreri AJ; Mollejo M; Piris MA; Baldini L; Soulier J; Thieblemont C; Canzonieri V; Gattei V; Marasca R; Franceschetti S; Gaidano G; Tucci A; Uccella S; Tibiletti MG; Dirnhofer S; Tripodo C; Doglioni C; Dalla Favera R; Cavalli F; Zucca E; Kwee I; Bertoni F
    Blood; 2011 Feb; 117(5):1595-604. PubMed ID: 21115979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
    Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
    Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.